Engie Prifti1,2, Eleni N Tsakiri1, Ergina Vourkou1, George Stamatakis3, Martina Samiotaki3, Efthimios M C Skoulakis1, Katerina Papanikolopoulou4. 1. Institute for Fundamental Biomedical Research, Biomedical Sciences Research Centre "Alexander Fleming", 34 Fleming Street, 16672, Vari, Greece. 2. Laboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, Iera Odos 75, 11855, Athens, Greece. 3. Institute for Bio-Innovation, Biomedical Sciences Research Centre "Alexander Fleming", 34 Fleming Street, 16672, Vari, Greece. 4. Institute for Fundamental Biomedical Research, Biomedical Sciences Research Centre "Alexander Fleming", 34 Fleming Street, 16672, Vari, Greece. papanikolopoulou@fleming.gr.
Correction to: Acta Neuropathologica Communications (2022) 10:44 10.1186/s40478-022-01348-1
Following publication of the original article [1], it was noted that due to a typesetting mistake, incorrect files for Additional files 6 and 7 were processed.The correct files for Additional files 6 and 7 are attached to this Correction and have been corrected in the original article. The publisher apologises to the authors and readers for the inconvenience caused by this error.Additional file 6: Fig. S5 Targeted proteomics to quantify cysteine oxidation. a Extracted chromatograms for the parent ions and isotopes (upper panel) and of its 6 most abundant fragments (daughter ions, lower panel) at the retention time 27.9 min of the NEM and carbamidomethyl labeled 322CGSLGNIHHKPGGGQVEVK peptide from representative samples of Tau and Tau co-overexpressed with Mical. b Spectra of the scan used for the library creation of the NEM (+ 125 Da) and carbamidomethyl (+ 57 Da) modified 322CGSLGNIHHKPGGGQVEVK peptide.Additional file 7: Fig. S6 a Representative Western blot of head lysates from flies expressing UAS-htauFLAG−2N4RC322A using elav-GAL4;Ras2-GAL4 and UAS-htauFLAG−2N4RC291A using elav-GAL4. Star indicates significant differences between the two groups. b Virgin elav-GAL4;Ras2-GAL4 females were crossed with UAS-Mic/CyO and UAS-Mic/CyO;UAS-C322A males. Bars represent the mean number of non-CyO bearing progeny over CyO flies ± SEM of the indicated genotypes. c Response of flies expressing UAS-htauFLAG−2N4RC291A upon treatment with paraquat for 28 h. Star indicates significant difference from the transgene without Mical overexpression. Control flies are elav-GAL4/+ (grey bar) and Mical are flies that overexpress Mical under the panneuronal driver (black bar). d Memory performance of animals expressing panneuronally the htauFLAG−2N4RC291A transgene (dark grey bar), compared with the same transgene upon co-expression with Mical (black bar). Star indicates significant difference between the two genotypes. Control flies (light grey bars) are driver elav-GAL4/+ flies (CN) and flies that overexpress Mical. The number of experimental replicates (n) is indicated within the bars.